Edwards Lifesciences Corporation
US ˙ NYSE ˙ US28176E1082

SecurityEW / Edwards Lifesciences Corporation
InstitutionBartlett & Co. LLC
Latest Disclosed Ownership6,375 shares
Latest Disclosed Value $ 489
Bartlett & Co. LLC ownership in EW / Edwards Lifesciences Corporation

On January 8, 2024 - Bartlett & Co. LLC filed a 13F-HR form disclosing ownership of 6,375 shares of Edwards Lifesciences Corporation (US:EW) valued at $486,094 USD as of December 31, 2023. The entity filed a previous 13F-HR on October 10, 2023 disclosing 6,375 shares of Edwards Lifesciences Corporation. The current value of the position is $547,995 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2024-01-08 2023-12-31 13F Edwards Lifesciences COM 28176E108 6,375 0 0.00 0 0.0079
2023-10-10 2023-09-30 13F Edwards Lifesciences COM 28176E108 6,375 0 0.00 0 0.0079
2023-07-14 2023-06-30 13F Edwards Lifesciences COM 28176E108 6,375 0 0.00 1 0.0104
2023-04-06 2023-03-31 13F Edwards Lifesciences COM 28176E108 6,375 0 0.00 1 -100.00 0.0102
2023-01-04 2022-12-31 13F Edwards Lifesciences COM 28176E108 6,375 0 0.00 0 -100.00 0.0096
2022-10-17 2022-09-30 13F Edwards Lifesciences COM 28176E108 6,375 0 0.00 527 -13.04 0.0113
2022-08-02 2022-06-30 13F Edwards Lifesciences COM 28176E108 6,375 -408 -6.02 606 -24.06 0.0123
2022-05-13 2022-03-31 13F Edwards Lifesciences COM 28176E108 6,783 0 0.00 798 -9.22 0.0139
2022-03-08 2021-12-31 13F Edwards Lifesciences COM 28176E108 6,783 240 3.67 879 18.62 0.0149
2021-10-15 2021-09-30 13F Edwards Lifesciences COM 28176E108 6,543 -6 -0.09 741 9.29 0.0141
2021-07-19 2021-06-30 13F Edwards Lifesciences COM 28176E108 6,549 0 0.00 678 23.72 0.0129
2021-04-19 2021-03-31 13F Edwards Lifesciences COM 28176E108 6,549 0 0.00 548 -8.21 0.0110
2021-01-20 2020-12-31 13F Edwards Lifesciences COM 28176E108 6,549 -84 -1.27 597 12.85 0.0127
2020-10-20 2020-09-30 13F Edwards Lifesciences COM 28176E108 6,633 0 0.00 529 15.50 0.0124
2020-08-03 2020-06-30 13F Edwards Lifesciences COM 28176E108 6,633 4,042 156.00 458 -6.34 0.0120
2020-05-07 2020-03-31 13F Edwards Lifesciences COM 28176E108 2,591 -315 -10.84 489 -23.47 0.0149
2019-11-04 2019-09-30 13F Edwards Lifesciences COM 28176E108 2,906 770 36.05 639 61.77 0.0168
2019-07-24 2019-06-30 13F Edwards Lifesciences COM 28176E108 2,136 0 0.00 395 -3.42 0.0147
2019-04-23 2019-03-31 13F Edwards Lifesciences COM 28176E108 2,136 0 0.00 409 25.08 0.0157
2019-01-23 2018-12-31 13F Edwards Lifesciences COM 28176E108 2,136 0 0.00 327 -12.10 0.0139
2018-10-15 2018-09-30 13F Edwards Lifesciences COM 28176E108 2,136 0 0.00 372 19.61 0.0140
2018-07-31 2018-06-30 13F Edwards Lifesciences COM 28176E108 2,136 -136 -5.99 311 -1.89 0.0126
2018-04-25 2018-03-31 13F Edwards Lifesciences COM 28176E108 2,272 -136 -5.65 317 16.97 0.0131
2018-01-19 2017-12-31 13F Edwards Lifesciences COM 28176E108 2,408 0 0.00 271 3.04 0.0108
2017-10-23 2017-09-30 13F Edwards Lifesciences COM 28176E108 2,408 0 0.00 263 -7.72 0.0110
2017-07-18 2017-06-30 13F Edwards Lifesciences COM 28176E108 2,408 0 0.00 285 25.55 0.0128
2017-04-25 2017-03-31 13F Edwards Lifesciences COM 28176E108 2,408 0 0.00 227 0.44 0.0103
2017-02-06 2016-12-31 13F Edwards Lifesciences COM 28176E108 2,408 0 0.00 226 -22.07 0.0107
2016-10-24 2016-09-30 13F Edwards Lifesciences COM 28176E108 2,408 0 0.00 290 20.83 0.0140
2016-07-27 2016-06-30 13F Edwards Lifesciences COM 28176E108 2,408 0 0.00 240 13.21 0.0118
2016-05-02 2016-03-31 13F Edwards Lifesciences COM 28176E108 2,408 0 0.00 212 11.58 0.0106
2016-02-04 2015-12-31 13F Edwards Lifesciences COM 28176E108 2,408 1,204 100.00 190 11.11 0.0098
2015-11-02 2015-09-30 13F Edwards Lifesciences COM 28176E108 1,204 0 0.00 171 0.00 0.0094
2015-08-03 2015-06-30 13F Edwards Lifesciences COM 28176E108 1,204 0 0.00 171 -0.58 0.0086
2015-05-01 2015-03-31 13F Edwards Lifesciences COM 28176E108 1,204 1,204 0.00 172 0.0085
2015-01-30 2014-12-31 13F Edwards Lifesciences COM 28176E108 0 -1,204 -100.00 0 -100.00
2014-10-27 2014-09-30 13F Edwards Lifesciences COM 28176E108 1,204 0 0.00 123 19.42 0.0059
2014-08-01 2014-06-30 13F Edwards Lifesciences COM 28176E108 1,204 0 0.00 103 15.73 0.0050
2014-05-05 2014-03-31 13F Edwards Lifesciences COM 28176E108 1,204 0 0.00 89 12.66 0.0044
2014-02-05 2013-12-31 13F Edwards Lifesciences COM 28176E108 1,204 0 0.00 79 -5.95 0.0039
2013-11-04 2013-09-30 13F Edwards Lifesciences COM 28176E108 1,204 0 0.00 84 3.70 0.0046
2013-07-30 2013-06-30 13F Edwards Lifesciences COM 28176E108 1,204 1,204 81 0.0045
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.